Operating Lease, Right-of-Use Asset of HTG MOLECULAR DIAGNOSTICS, INC from 31 Mar 2019 to 31 Mar 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
HTG MOLECULAR DIAGNOSTICS, INC quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Mar 2019 to 31 Mar 2023.
  • HTG MOLECULAR DIAGNOSTICS, INC Operating Lease, Right-of-Use Asset for the quarter ending 31 Mar 2023 was $892,685, a 28% decline year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

HTG MOLECULAR DIAGNOSTICS, INC Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q1 2023 $892,685 -$352,360 -28% 31 Mar 2023 10-Q 11 May 2023 2023 Q1
Q4 2022 $1,007,202 -$338,159 -25% 31 Dec 2022 10-Q 11 May 2023 2023 Q1
Q3 2022 $1,039,999 -$404,349 -28% 30 Sep 2022 10-Q 10 Nov 2022 2022 Q3
Q2 2022 $1,143,270 +$896,949 +364% 30 Jun 2022 10-Q 12 Aug 2022 2022 Q2
Q1 2022 $1,245,045 +$895,971 +257% 31 Mar 2022 10-Q 12 May 2022 2022 Q1
Q4 2021 $1,345,361 +$336,264 +33% 31 Dec 2021 10-K 30 Mar 2023 2022 FY
Q3 2021 $1,444,348 +$698,163 +94% 30 Sep 2021 10-Q 10 Nov 2021 2021 Q3
Q2 2021 $246,321 -$659,138 -73% 30 Jun 2021 10-Q 12 Aug 2021 2021 Q2
Q1 2021 $349,074 -$689,971 -66% 31 Mar 2021 10-Q 13 May 2021 2021 Q1
Q4 2020 $1,009,097 -$200,048 -17% 31 Dec 2020 10-K 29 Mar 2022 2021 FY
Q3 2020 $746,185 -$624,004 -46% 30 Sep 2020 10-Q 10 Nov 2020 2020 Q3
Q2 2020 $905,459 -$489,205 -35% 30 Jun 2020 10-Q 11 Aug 2020 2020 Q2
Q1 2020 $1,039,045 +$417,616 +67% 31 Mar 2020 10-Q 13 May 2020 2020 Q1
Q4 2019 $1,209,145 31 Dec 2019 10-K 25 Mar 2021 2020 FY
Q3 2019 $1,370,189 30 Sep 2019 10-Q 12 Nov 2019 2019 Q3
Q2 2019 $1,394,664 30 Jun 2019 10-Q 06 Aug 2019 2019 Q2
Q1 2019 $621,429 31 Mar 2019 10-Q 09 May 2019 2019 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.